Alwitry A, West S, King J, Foss A J, Abercrombie L C
Eye, Ear, Nose and Throat Centre, Queens Medical Centre, Nottingham, United Kingdom.
Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb;23(1):11-5. doi: 10.1097/01.iop.0000249429.02757.6b.
To present long-term follow-up data on enucleations and eviscerations carried out with placement of spherical porous polyethylene implants.
A retrospective, interventional, noncomparative case series of all patients undergoing primary evisceration or enucleation surgery from one teaching hospital ophthalmology department.
In total, 106 cases were identified. Eighty patients (75.5%) underwent enucleation (group A) and 26 (24.5%) underwent evisceration (group B). Patient demographics were similar in both groups. Mean implant size in group A was 20.5 mm and 17.2 mm in group B. Mean follow-up in group A was 40 months (range, 12 to 80 months). Mean follow-up in group B was 63 months (range, 12 to 72 months). Six cases (7.5%) in group A had complications (excluding implant exposure), whereas one case (3.8%) in group B had a complication (excluding implant exposure). Five patients (6.3%) in group A had implant exposure; 14 cases (53.8%) of implant exposure occurred in group B.
Our case series revealed a significantly higher incidence of implant exposure after evisceration than after enucleation. Our data suggest that enucleation should be the procedure of choice when removing an eye to minimize the risk of subsequent complications, particularly orbital implant exposure.
呈现关于植入球形多孔聚乙烯植入物后进行眼球摘除术和眼内容剜出术的长期随访数据。
对一家教学医院眼科所有接受初次眼内容剜出术或眼球摘除术的患者进行回顾性、介入性、非对照病例系列研究。
共确定106例病例。80例患者（75.5%）接受了眼球摘除术（A组），26例（24.5%）接受了眼内容剜出术（B组）。两组患者的人口统计学特征相似。A组植入物的平均尺寸为20.5毫米，B组为17.2毫米。A组的平均随访时间为40个月（范围12至80个月）。B组的平均随访时间为63个月（范围12至72个月）。A组有6例（7.5%）出现并发症（不包括植入物暴露），而B组有1例（3.8%）出现并发症（不包括植入物暴露）。A组有5例患者（6.3%）出现植入物暴露；B组有14例（53.8%）发生植入物暴露。
我们的病例系列显示，眼内容剜出术后植入物暴露的发生率明显高于眼球摘除术后。我们的数据表明，在摘除眼球时，眼球摘除术应作为首选手术，以尽量降低后续并发症的风险，特别是眼眶植入物暴露的风险。
